Date:
January 25, 2021
Time:
all-day
Place:
Virtual
Virtual PMWC COVID-19 January 25-27th, 2021
The COVID-19 emergency has motivated the research community to reach inspiring new heights – many investigators have pivoted their programs to collectively take virtually every approach to study COVID-19 and SARS CoV-2, from mechanisms of infection to clinical treatment, therapy development, and population studies
PMWC has created a pivotal three-day conference that touches upon all of these elements.
The speaker lineup includes leaders from across academia, pharma, healthcare provider, regulatory, and the commercial solution delivery space:
- Adrian Hill, Oxford University
- Aaron Tobian, Johns Hopkins
- Aashish Manglik, UCSF
- Amy Compton-Phillip, Providence St. Joseph Health
- Andrew Hemmert, BioFire Diagnostics
- Andrew von Eschenbach, Samaritan Health Initiatives
- Anne Wyllie, Yale School of Public Health
- Anthony Fauci, US National Inst. of Allergy & Infectious Disease (NIAID)
- Anu Osinusi, Gilead Sciences
- Ashley Mason, UCSF
- Bruce Patterson, incellDx
- Carlos Bustamante, UCSF
- Catherine Blish, Stanford University School of Medicine
- Christopher Mason, Weill Cornell Medicine
- Connie Szczepanek, Cancer Research Consortium of West Michigan (CRCWM)
- Danielle Swaney, UCSF
- Diane Havlir, San Francisco General Hospital
- Fareed Melhem, Medidata Solutions
- Hanneke Schuitemaker, Amsterdam University Medical Ctr.
- Harpreet Rai, Oura Ring
- Helmy Eltoukhy, Guardant Health
- Ida Grundberg, Olink Proteomics
- Ira Mellman, Genentech
- James Heath, Inst. for Systems Biology
- James Lu, Helix
- Jane Perlmutter, Gemini Group
- Janet Woodcock, FDA
- Janice Chen, Mammoth Biosciences
- Jeffrey Balser, Vanderbilt University
- Jennifer Radin, Scripps Research Translational Inst.
- Jessica Mega, Verily Life Sciences
- Jia Xin Annie Yu, Cancer Research Inst.
- Joel Dudley, Tempus
- John Moore, Fitbit
- Jonathan Rothberg, 4Catalyzer
- Joseph DeRisi, UCSF, Chan Zuckerberg Biohub
- Keith Yamamoto, UCSF
- Kevin Hrusovsky, Powering Precision Health
- Kirsten Bibbins-Domingo, UCSF
- Kristen Azar, Sutter Health
- Kristina McGuire, Regeneron
- Lance Baldo, Adaptive Biotech
- Lars Steinmetz, SOPHiA Genetics
- Lee Hood, Providence Health
- Marcia Eisenberg, LabCorp
- Marty Tenenbaum, Cancer Commons
- Maximilian Konig, Johns Hopkins School of Medicine
- Michael Snyder, Stanford Ctr. of Genomics & Personalized Medicine
- Monica Herrera, Bio-Rad
- Nathan Pennell, Cleveland Clinic Taussig Cancer Inst.
- Omer Bayraktar, Wellcome Sanger Institute
- Patrice Hugo, Q2 Solutions
- Peter Marks, FDA
- Ralph Snyderman, Duke University
- Richard Schilsky, ASCO
- Ruth Clements, Quest Diagnostics
- Ruth March, AstraZeneca
- Sarah Warren, NanoString Tech
- Sheila Walcoff, Goldbug Strategies
- Steven Quay, Atossa
- Susana Rojas, Calle 24 Latino Cultural District
- Tal Zaks, Moderna
- Yvonne Maldonado, Stanford University School of Medicine
